EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies
The mission of the UCL The Centre for Doctoral Training in Emergent Macromolecular Therapies is to train the bioprocess engineering research leaders of the future who will deliver translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs.
The CDT is funded by the Engineering and Physical Sciences Research Council (EPSRC) and will award 7 PhD studentships a year until 2018. Each studentship is for four years and will be undertaken at UCL or one of several CDT collaborating universities. All researchers undertake 18 weeks of taught training which includes residential Summer and Autumn Camps.
Our research is at the cutting edge of process engineering and is aimed at developing new and improved processes for the next generation of biopharmaceuticals. The research is aligned to the Centre for Innovative Manufacture of Emergent Macromolecular Therapies which is also hosted at UCL. This gives all CDT students access to a consortium of key industry leaders, and an opportunity to present their work to the wider Bioprocessing community.
The new EPSRC CDT in Emergent Macromolecular Therapies will run its third cohort of PhD students in Oct 2017.
Applications are invited to host CDT Studentships starting in October 2018.
PhD students can be based at any HEI and at least 65% are intended to be based outside of UCL, however, we do require a collaborative link to UCL and the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies. Researchers will undertake 12 weeks of taught training of core modules as part of a cohort and participate in Centre events.
The deadline for proposals is 15 December 2017.
*Please contact us for this form in other formats.